FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr

Why did UnitedHealth’s stock plunge recently? How are Trump’s tariffs impacting U.S. retailers? What caused Nvidia CEO to call chip export policy a failure? Why is Target cutting its sales outlook? How is Bitcoin reaching new all-time highs? What’s the effect of rising U.S. Treasury yields on stocks? Why did OpenAI buy Jony Ive’s hardware startup? How are AI advancements reshaping business strategies? What’s behind Walmart’s response to Trump’s tariffs?

FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr

benzinga.com/government/regulations/25/05/45537919/fda-limits-annual-covid-19-boosters-to-high-risk-americans-demands-new-trials-for-healthy-

The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter clinical trial requirements for healthy adults.
What Happened: The FDA will now require…

This story appeared on benzinga.com, 2025-05-21 10:42:56.